Last reviewed · How we verify
sevoflurane or isoflurane
At a glance
| Generic name | sevoflurane or isoflurane |
|---|---|
| Sponsor | Austin Health |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival (PHASE3)
- Total Intravenous Anesthesia (TIVA) Versus Inhalational Anesthesia at The End of Laparoscopic Obstetric Surgery Regarding Postoperative Nausea and Vomiting (NA)
- GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (PHASE3)
- General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial (PHASE4)
- Interaction of Volatile Anesthetics With Magnesium (PHASE4)
- Anesthesia and Non-small Cell Lung Cancer Recurrence (PHASE4)
- Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty (EARLY_PHASE1)
- Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sevoflurane or isoflurane CI brief — competitive landscape report
- sevoflurane or isoflurane updates RSS · CI watch RSS
- Austin Health portfolio CI